Portfolio (Quarterly)
Guide ↗
GF FUND MANAGEMENT CO. LTD.
· CIK 0002057060| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 541 | CCCC | C4 Therapeutics Inc | Healthcare | 2,012.0 | $9K | — | NEW | — | $4.67 | -36.2% |
| 542 | ALX | Alexander's Inc | Real Estate | 34.0 | $9K | — | NEW | — | $275.56 | -10.3% |
| 543 | SGMT | Sagimet Biosciences Inc | Healthcare | 1,210.0 | $9K | — | NEW | — | $7.73 | +19.5% |
| 544 | EOLS | Evolus Inc | Healthcare | 1,346.0 | $9K | — | NEW | — | $6.94 | +14.8% |
| 545 | ENTA | Enanta Pharmaceuticals Inc | Healthcare | 617.0 | $9K | — | NEW | — | $14.58 | -18.5% |
| 546 | KMDA | Kamada Ltd | Healthcare | 1,223.0 | $9K | — | NEW | — | $7.34 | +18.8% |
| 547 | PBYI | Puma Biotechnology Inc | Healthcare | 1,080.0 | $9K | — | NEW | — | $8.11 | +20.5% |
| 548 | GOOD | Gladstone Commercial Corp | Real Estate | 657.0 | $8K | — | NEW | — | $12.30 | +1.6% |
| 549 | — | Upstream Bio Inc | — | 1,145.0 | $8K | — | NEW | — | $6.92 | — |
| 550 | RCKT | Rocket Pharmaceuticals Inc | Healthcare | 2,300.0 | $8K | — | NEW | — | $3.42 | -24.1% |
| 551 | AVIR | Atea Pharmaceuticals Inc | Healthcare | 1,656.0 | $8K | — | NEW | — | $4.65 | +11.2% |
| 552 | NXRT | NexPoint Residential Trust Inc | Real Estate | 275.0 | $8K | — | NEW | — | $27.92 | -29.7% |
| 553 | VNDA | Vanda Pharmaceuticals Inc | Healthcare | 1,234.0 | $8K | — | NEW | — | $6.12 | -17.5% |
| 554 | OABI | OmniAb Inc | Healthcare | 2,973.0 | $7K | — | NEW | — | $2.46 | +87.4% |
| 555 | LXEO | Lexeo Therapeutics Inc | Healthcare | 1,545.0 | $7K | — | NEW | — | $4.66 | -28.9% |
| 556 | LRMR | Larimar Therapeutics Inc | Healthcare | 2,300.0 | $7K | — | NEW | — | $3.05 | +0.8% |
| 557 | BFS | Saul Centers Inc | Real Estate | 185.0 | $7K | — | NEW | — | $37.39 | -19.8% |
| 558 | KROS | Keros Therapeutics Inc | Healthcare | 631.0 | $7K | — | NEW | — | $10.70 | +8.6% |
| 559 | IMRX | Immuneering Corp | Healthcare | 1,341.0 | $7K | — | NEW | — | $4.99 | -14.4% |
| 560 | AUTL | Autolus Therapeutics PLC | Healthcare | 4,154.0 | $7K | — | NEW | — | $1.60 | +15.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
70.8%
Consumer Cyclical
9.0%
Communication Services
6.0%
Healthcare
4.5%
Consumer Defensive
3.9%
Industrials
1.9%
Energy
1.8%
Utilities
0.8%
Financial Services
0.6%
Basic Materials
0.6%